Arovella Therapeutics Ltd
1 clinical trials · Sponsor
◉ Watch Arovella Therapeutics Ltd
| Record | Firm | Date |
|---|---|---|
| Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. (NCT07518329) | Arovella Therapeutics Ltd | 2026-08-20 |
Track Arovella Therapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.